Research Article
Immune Cell Response during COVID-19 Infection and following SARS-CoV-2 Vaccination in Patients Admitted to Intensive Care Unit
Table 2
The different types and doses of vaccine.
| | Pfizer/BioNTech | Astra Zeneca | Sinopharm | Moderna | Janssen | Total | Deceased | Discharged |
| | Patients (n) | 22 | 12 | 6 | 1 | 1 | 42 | 24 | 18 | | Doses | | 1 dose | 7 | 4 | 0 | 0 | 1 | 12 | 12 | 0 | | 2 doses | 9 | 8 | 5 | 1 | 0 | 23 | 9 | 14 | | 3 doses | 6 | 0 | 1 | 0 | 0 | 7 | 3 | 4 | | Deceased | 11 | 8 | 5 | 0 | 1 | – | – | – | | Discharged | 11 | 4 | 1 | 1 | 0 | – | – | – | | COVID-19 infection postvaccination (min–max) | 2–8 months |
|
|
